The American Journal of Medicine
Volume 122, Issue 2, Supplement , Pages S22-S32, February 2009

Safety of Bisphosphonates in the Treatment of Osteoporosis

  • Robert R. Recker, MD

      Affiliations

    • School of Medicine, Creighton University, Omaha, Nebraska, USA
    • ,
  • E. Michael Lewiecki, MD

      Affiliations

    • New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico, USA
    • Corresponding Author InformationRequests for reprints should be addressed to E. Michael Lewiecki, MD, New Mexico Clinical Research & Osteoporosis Center, 300 Oak Street NE, Albuquerque, New Mexico 87106
    • ,
  • Paul D. Miller, MD

      Affiliations

    • Colorado Center for Bone Research, Lakewood, Colorado, USA
    • ,
  • James Reiffel, MD

      Affiliations

    • Columbia University, New York, New York, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9343(08)01192-3

doi:10.1016/j.amjmed.2008.12.004

The American Journal of Medicine
Volume 122, Issue 2, Supplement , Pages S22-S32, February 2009

Article Tools

* Image Usage & Resolution